公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2019 | Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Effect of Chronic Kidney Disease on the Disposition of Hepatic CYP2C8 and OATP1B Drug Substrates | Tan M.-L.; Zhao P.; Zhang L.; YUNN-FANG HO ; Varma M.V.S.; Neuhoff S.; Nolin T.D.; Galetin A.; Huang S.-M. | Clinical Pharmacology and Therapeutics | 55 | 43 |